parallax background

Supervisor Database Search

Search for supervisors below. You can filter your search using the options and select
multiple fields by holding CTRL (Cmd on Mac) + clicking multiple options in a list.

The ICAT Supervisor list is reviewed annually by the partner universities and updated online in March/April each year. You can read the ICAT supervisor policy here.

Full NameDr Suneil Jain

Centre for Cancer Research and Cell Biology

Queen's University Belfast

Webpage:qub.ac.uk

Email Address:Email hidden; Javascript is required.

Research Fields
  • genetics, genomics and molecular biology
  • cancer/oncology
  • bioengineering/medical devices
  • clinical trials
Postgrad Medical Specialties
  • Medicine
  • Surgery
  • Pathology
  • Public Health
  • Sports and Exercise Medicine
Medical Subspecialties
  • Health Informatics
  • Hospice and palliative medicine
  • Oncology
My Work

Prostate cancer clinical and translational research, particularly advanced radiotherapy, stereotactic, brachytherapy, drug-radiation combination studies and biomarkers. I am a clinical-translational academic clinical oncologist, I work with a very large, collaborative research group focussed on prostate cancer. We comprise clinicians, medical physicists, radiobiologists, molecular biologists, pathologists and bioinformaticians. I collaborate closely with several institutions, particularly, University of Manchester, University of Toronto, Institute of Cancer Research and Royal Marsden, Trinity College Dublin and DIT.

Recent key abstracts or papers:

Jain S, Lyons C, Walker SM, et al. A metastatic biology gene expression assay to predict the risk of distant metastases in patients with localized prostate cancer treated with primary radical treatment. Journal of Clinical Oncology 2017; 35(6_suppl): 11.

Nicolae, A, Morton G, Chung H, Loblaw A, Jain S, Mitchell D, Lin L, Helou J, Heath E, Ravi A. Evaluation of a machine-learning algorithm for treatment planning in prostate Low-Dose-Rate brachytherapy. IJROBP. 2016 (in press 2017).

Chen, R. C., R. B. Rumble, D. A. Loblaw, A. Finelli, B. Ehdaie, M. R. Cooperberg, S. C. Morgan, S. Tyldesley, J. J. Haluschak, W. Tan, S. Justman, And S. Jain. "Active surveillance for the management of localized prostate cancer (Cancer Care Ontario guideline): American Society of Clinical Oncology Clinical Practice guideline endorsement." Journal of Clinical Oncology (2016). J Clin Oncol. 2016;34(18):2182-90.

Mateo J, Carreira S, Sandhu, S, Mossop M, Perez-Lopez R, Rodrigues D, Robinson D, Omlin A, Tunariu N, Boysen G, Porta N, Flohr P, Gillman A, Paulding C, Seed G, Jain S, Hussain S, Jones R, Elliott T, McGovern U…Knudsen K, Feng F, Chinnaiyan A, Hall E, De Bono J. DNA repair defects and PARP inhibition in Metastatic Prostate Cancer. New England Journal of Medicine (NEJM) October 2015.

Klotz L, Vesprini D, Sethukavalan, P, Jethava V, Zhang L, Jain S, Yamamoto T, Mamedov A, Loblaw A. Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. Journal of Clinical Oncology (JCO) 2015 33(3) 272-277.